Alarm symptoms, risk factors for digestive tract cancer and readiness to participate in an endoscopic screening program

Przeglad Gastroenterologiczny

Volumn 8, Issue 2, 2013, Pages 108-114

  Ziółkowski, Bartłomiej Antoni ^a   Pacholec, Agnieszka ^a   Muszyński, Jacek Teodor ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Colorectal cancer; Prevalence; Public awareness

Indexed keywords

ABDOMINAL PAIN; ADULT; AGED; ALCOHOL CONSUMPTION; ANTHROPOMETRIC PARAMETERS; ARTICLE; CANCER RISK; CANCER SCREENING; COMORBIDITY; CONSTIPATION; DECISION MAKING; DIABETES MELLITUS; DIARRHEA; DIGESTIVE SYSTEM CANCER; DYSPHAGIA; EDUCATIONAL STATUS; ENDOSCOPY; FAMILY HISTORY; FEEDING BEHAVIOR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELENA; PREVALENCE; RISK FACTOR; SMOKING; SYMPTOM; VOMITING;

EID: 84878466014     PISSN: 18955770     EISSN: 18974317     Source Type: Journal    
DOI: 10.5114/pg.2013.34836     Document Type: Article

References (36)

1. Verdecchia A, Santaquilani M, Sant M. Survival for cancer patients in Europe. Ann Ist Super Sanita 2009; 45: 315-24.
2. Tables by population, regions, and sex for Western Europe, Northern Europe, Southern Europe, Central and Eastern Europe (except Russian Federation), incidence expressed as number of cases, for males and females for colon and rectum as compared to other cancer sites: the Globocan 2004 database. Lyon, France: International Agency for Research on cancer, (http://www-dep.iarc.fr).
3. Segnan N, Senore C, Andreoni B, et al. SCORE3 Working Group- Italy. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. Gastroenterology 2007; 132: 2304-12. (Pubitemid 46900821)
4. Harewood GC, Murray F, Patchett S, et al. Assessment of colorectal cancer knowledge and patient attitudes towards screening: is Ireland ready to embrace colon cancer screening? Ir J Med Sci 2009; 178: 7-12.
5. Reguła J, Rupinski M, Kraszewska E, et al. Colonoscopy in colorectal- cancer screening for detection of advanced neoplasia. N Engl J Med 2006; 355: 1863-72. (Pubitemid 44664644)
6. Ziółkowski BA, Pacholec A, Kudlicka M, et al. Prevalence of abdominal symptoms in the Polish population. Prz Gastroenterol 2012; 7: 20-5.
7. Raport z wyników Narodowego Spisu Ludnosci i Mieszkan, Główny Urzad Statystyczny. 2002 http://www.stat.gov.pl/cps/rde/ xbcr/gus/PUBL-raport-z-wynikow-nsp-ludnosci-i-mieszkan-2002.pdf.
8. Zdrojewski T, Bandosz P, Szpakowski P. Rozpowszechnienie głównych czynników ryzyka chorób układu sercowo-naczyniowego w Polsce. Wyniki badania NATPOL PLUS. Kardiol Pol 2004; 64 (Suppl 4): S5-22.
9. Keighley MR, O'Morain C, Giacosa A, et al. United European Gastroenterology Federation Public Affairs Committee. Public awareness of risk factors and screening for colorectal cancer in Europe. Eur J Cancer Prev 2004; 13: 257-62. (Pubitemid 39096077)
10. Meineche-Schmidt V, Krag E. Dyspepsia in general practice in Denmark. A 1-year analysis of consulters in general practice. Scand J Prim Health Care 1998; 16: 216-21. (Pubitemid 29044973)
11. Bodger K, Daly MJ, Heatley RV. Prescribing patterns for dyspepsia in primary care: a prospective study of selected general practitioners. Aliment Pharmacol Ther 1996; 10: 889-95. (Pubitemid 26412916)
12. Bołdys H, Marek TA, Wanczura P, et al. Even young patients with no alarm symptoms should undergo endoscopy for earlier diagnosis of gastric cancer. Endoscopy 2003; 35: 61-7. (Pubitemid 36131252)
13. Maconi G, Kurihara H, Panizzo V. Gastric cancer in young patients with no alarm symptoms: focus on delay in diagnosis, stage of neoplasm and survival. Scand J Gastroenterol 2003; 38: 1249-55. (Pubitemid 38096083)
14. Fransen GA, Janssen MJ, Muris JW. Meta-analysis: the diagnostic value of alarm symptoms for upper gastrointestinal malignancy Aliment Pharmacol Ther 2004; 20: 1045-52. (Pubitemid 39657937)
15. Nikpour S, Asgari AA. Colonoscopic evaluation of minimal rectal bleeding in average-risk patients for colorectal cancer. World J Gastroenterol 2008; 14: 6536-40.
16. Talley NJ, Jones M. Self-reported rectal bleeding in a United States community: prevalence, risk factors, and health care seeking. Am J Gastroenterol 1998; 93: 2179-83. (Pubitemid 29076871)
17. Yusuf S, Hawken S, Ounpuu S, et al. INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937-52. (Pubitemid 39208455)
18. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002; 347: 1175-86.
19. Yang P, Zhou Y, Chen B, et al. Overweight, obesity and gastric cancer risk: results from a meta-analysis of cohort studies. Eur J Cancer 2009; 45: 2867-73.
20. Jee SH, Yun JE, Park EJ, et al. Body mass index and cancer risk in Korean men and women. Int J Cancer 2008; 123: 1892-6.
21. Huerta JM, Navarro C, Chirlaque MD, et al. Prospective study of physical activity and risk of primary adenocarcinomas of the oesophagus and stomach in the EPIC (European Prospective Investigation into Cancer and Nutrition) cohort. Cancer Causes Control 2010; 21: 657-69.
22. Yamaji Y, Watabe H, Yoshida H, et al. High-risk population for gastric cancer development based on serum pepsinogen status and lifestyle factors. Helicobacter 2009; 14: 81-6.
23. Giacosa A, Franceschi S, La Vecchia C, et al. Energy intake, overweight, physical exercise and colorectal cancer risk. Eur J Cancer Prev 1999; 8 (Suppl 1): 53-60.
24. Anderson JC, Messina CR, Dakhllalah F, et al. Body mass index: a marker for significant colorectal neoplasia in a screening population. J Clin Gastroenterol 2007; 41: 285-90. (Pubitemid 46340751)
25. Yoshida I, Suzuki A, Vallee M, et al. Seruminsulin levels and the prevalence of adenomatous and hyperplastic polyps in the proximal colon. Clin Gastro Hepatol 2006; 4: 1225-31. (Pubitemid 44512215)
26. Chiu HM, Lin JT, Shun CT, et al. Association of metabolic syndrome with proximal and synchronous colorectal neoplasm. Clin Gastroenterol Hepatol 2007; 5: 221-9.
27. Anderson JC, Atam R, Alpern Z, et al. Prevalence of colorectal neoplasia in smokers. Am J Gastroenterol 2003; 98: 2777-83. (Pubitemid 38020123)
28. Lieberman DA, Prindiville S, Weiss DG, et al. Risk factors for advanced colonic neoplasia and hyperplastic polyps. JAMA 2003; 290: 2959-67. (Pubitemid 37505528)
29. Hannan LM, Jacobs EJ, Thun MJ. The association between cigarette smoking and risk of colorectal cancer in a large prospective cohort from the United States. Cancer Epidemiol Biomarkers Prev 2009; 18: 3362-7.
30. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001; 37 (Suppl 8): S4-66.
31. Parkin DM, Bray F, Ferlay J, et al. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94: 153-6. (Pubitemid 32911406)
32. Harewood GC, Wiersema MJ, Melton LJ 3rd. A prospective, controlled assessment of factors influencing acceptance of screening colonoscopy. Am J Gastroenterol 2002; 97: 3186-94. (Pubitemid 35428814)
33. Segnan N, Senore C, Andreoni B, et al. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. Gastroenterology 2007; 132: 2304-12. (Pubitemid 46900821)
34. Coups EJ, Manne, SL Meropol NJ, et al. Multiple behavioral risk factors for colorectal cancer and colorectal cancer screening status. Cancer Epidemiol Biomarkers Prev 2007; 16: 510-6. (Pubitemid 46548654)
35. Subramanian S, Amonkar MM, Hunt TL. Use of colonoscopy for colorectal cancer screening: evidence from the 2000 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 2005; 14: 409-16. (Pubitemid 40270105)
36. UK Flexible Sigmoidoscopy Screening Trial Investigators. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet 2002; 359: 1291-300.